NEW YORK, March 24, 2017 -- Pomerantz LLP announces that a class action lawsuit has been filed against Roadrunner Transportation Systems Inc. (“Roadrunner” or the “Company”) (NYSE:RRTS) and certain of its officers. The class action, filed in United States District Court, Eastern District of Wisconsin, is on behalf of a class consisting of investors who purchased or otherwise acquired Roadrunner securities, seeking to recover compensable damages caused by defendants’ violations of the Securities Exchange Act of 1934.
If you are a shareholder who purchased Roadrunner securities between May 8, 2014 and January 30, 2017, both dates inclusive, you have until April 3, 2017 to ask the Court to appoint you as Lead Plaintiff for the class. A copy of the Complaint can be obtained at www.pomerantzlaw.com. To discuss this action, contact Robert S. Willoughby at [email protected] or 888.476.6529 (or 888.4-POMLAW), toll free, ext. 9980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and number of shares purchased.
[Click here to join this class action]
Roadrunner is an asset-light transportation and logistics services provider that purports to offer a comprehensive suite of global supply chain solutions, including truckload logistics, customized and expedited less-than-truckload, intermodal solutions, freight consolidation, inventory management, expedited services, air freight, international freight forwarding, customs brokerage, and transportation management solutions. Roadrunner utilizes a broad third-party network of transportation providers, comprised of independent contractors and purchased power providers, with a focus on mid-size shippers. At all relevant times Morgan Southern, Inc. (“Morgan Southern”) and Bruenger Trucking (“Bruenger”) were among the Company’s subsidiaries.
The Complaint alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants made false and/or misleading statements and/or failed to disclose that: (i) the Company’s Morgan Southern and Bruenger subsidiaries had engaged in improper accounting practices; (ii) Roadrunner lacked effective internal controls; (iii) as a result, Roadrunner overstated its earnings throughout the Class Period by tens of millions of dollars; and (iv) as a result of the foregoing, Roadrunner’s financial statements were materially false and misleading at all relevant times.
On January 30, 2017, post-market, Roadrunner announced that in November 2016, the Company “was made aware of various potential accounting discrepancies at its Morgan Southern and Bruenger operating subsidiaries” and commenced an investigation with the assistance of outside counsel. While the investigation remains ongoing, Roadrunner advised investors that the Company “currently estimates it will require prior period adjustments to Roadrunner’s results of operations of between $20 million and $25 million” in the Company’s annual and quarterly financial reporting for the years 2014, 2015, and 2016. Roadrunner advised investors that the errors “principally relate to unrecorded expenses from unreconciled balance sheet accounts including cash, driver and other receivables, and linehaul and other driver payables,” and that the Company is reassessing its internal controls over financial reporting and its compliance programs.
On this news, Roadrunner’s share price fell $3.62, or 31.37%, to close at $7.92 on January 31, 2017.
The Pomerantz Firm, with offices in New York, Chicago, Florida, and Los Angeles, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 80 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com
CONTACT: Robert S. Willoughby Pomerantz LLP [email protected]


Anthropic Launches HIPAA-Compliant Healthcare Tools for Claude AI Amid Growing Competition
Lynas CEO Amanda Lacaze to Retire After 12 Years as Rare Earths Demand Grows
Rio Tinto–Glencore Talks Spark Pressure on BHP as Copper Fuels Mining Mega Deals
Boeing 737 MAX 10 Advances in FAA Testing as Certification Delays Continue
China’s AI Sector Pushes to Close U.S. Tech Gap Amid Chipmaking Challenges
Walmart to Join Nasdaq-100 Index as It Replaces AstraZeneca Following Exchange Move
Chevron Sees Path to Boost Venezuela Oil Output by 50% After Trump Administration Talks
Elon Musk Says X Will Open-Source Its Algorithm Amid EU Scrutiny
Nvidia Denies Upfront Payment Requirement for H200 AI Chips Amid China Export Scrutiny
Supreme Court to Hear Cisco Appeal on Alien Tort Statute and Human Rights Liability
NYC Nurses Strike Shuts Down 10 Private Hospitals as 15,000 Demand Safer Staffing and Benefits
AbbVie Commits $100 Billion to U.S. Investment in Drug Pricing Deal With Trump Administration
BlackRock to Cut Around 250 Jobs as CEO Larry Fink Pushes Strategic Shift
Trump Considers Starlink to Restore Internet Access in Iran Amid Protests
Trump Pushes Tech Giants to Absorb AI Data Center Power Costs, Citing Microsoft Changes
Merck Raises Growth Outlook, Targets $70 Billion Revenue From New Drugs by Mid-2030s
FTC Blocks Edwards Lifesciences’ JenaValve Acquisition in Major Antitrust Ruling 



